INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 48 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $52,625 | +31.6% | 250,000 | 0.0% | 0.01% | +22.2% |
| Q1 2023 | $40,000 | -71.2% | 250,000 | 0.0% | 0.01% | -70.0% |
| Q4 2022 | $138,750 | -53.4% | 250,000 | 0.0% | 0.03% | -51.6% |
| Q3 2022 | $298,000 | +88.6% | 250,000 | 0.0% | 0.06% | +87.9% |
| Q2 2022 | $158,000 | -44.6% | 250,000 | 0.0% | 0.03% | -35.3% |
| Q1 2022 | $285,000 | -49.4% | 250,000 | 0.0% | 0.05% | -42.0% |
| Q4 2021 | $563,000 | -34.2% | 250,000 | 0.0% | 0.09% | -36.7% |
| Q3 2021 | $855,000 | +14.3% | 250,000 | 0.0% | 0.14% | +23.0% |
| Q2 2021 | $748,000 | -53.7% | 250,000 | -50.0% | 0.11% | -18.1% |
| Q1 2021 | $1,616,000 | +204.9% | 500,000 | +100.0% | 0.14% | +34.0% |
| Q4 2020 | $530,000 | +81.5% | 250,000 | 0.0% | 0.10% | +98.1% |
| Q3 2020 | $292,000 | +29.2% | 250,000 | 0.0% | 0.05% | +30.0% |
| Q2 2020 | $226,000 | -46.1% | 250,000 | -50.0% | 0.04% | -63.6% |
| Q1 2020 | $419,000 | -12.7% | 500,000 | 0.0% | 0.11% | +44.7% |
| Q4 2019 | $480,000 | – | 500,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |